Using conditional knock-in mouse models, we and others have shown that despite the very high sequence identity between Nras and Kras proteins, oncogenic Kras displays a much stronger leukemogenic activity than oncogenic Nras in vivo. In this manuscript, we will summarize our recent work of characterizing wild-type Kras function in adult hematopoiesis and in oncogenic Kras-induced leukemogenesis. We attribute the strong leukemogenic activity of oncogenic Kras to 2 unique aspects of Kras signaling. First, Kras is required in mediating cell type-and cytokine-specific ERK1/2 signaling. Second, oncogenic Kras, but not oncogenic Nras, induces hyperactivation of wild-type Ras, which significantly enhances Ras signaling in vivo. We will also discuss a possible mechanism that mediates oncogenic Krasevoked hyperactivation of wild-type Ras and a potential approach to down-regulate oncogenic Kras signaling. In mammals, there are 3 Ras genes (Hras, Nras, and Kras) encoding 4 homologous 21kD proteins: Hras, Nras, Kras4A and Kras4B. 1 The first 85 amino-terminal residues are identical and the middle 78 amino acids share an 85% -90% identity among all Ras isoforms, while the last 25 amino acids at the carboxyl-terminus are highly variable. 2 In haematopoietic neoplasms, oncogenic mutations in the NRAS and KRAS genes are common, but rare in the HRAS gene. 2 Despite the high similarity in protein sequences and largely overlapping expression patterns, accumulating evidence suggest that Kras G12D/C expressed from its endogenous locus demonstrates much stronger leukemogenic activity than oncogenic Nras alleles (including Nras G12D alleles) (Fig. 1). Using conditional knock-in mouse models, we and others characterized multiple oncogenic Ras alleles in a pure C57BL/6 background, including the weak Nras G12D/ C , the intermediate Nras Q61R/C and Nras G12D/G12D , and the strong Kras G12D/C . 3-8 All of these models involve a conditional knock-in oncogenic Ras allele and the interferon-inducible Mx1-Cre. Upon polyinosinic-polycytidylic acid (pI-pC) injections to induce the expression of Cre and subsequently the oncogenes, Kras G12D/C mice die rapidly, while Nras G12D/G12D and Nras G12D/C mice show incrementally prolonged survival (Fig. 1A). To eliminate the impact of acute interferon signaling on animal survival, we also took advantage of the leaky expression of Mx1-Cre over the time. Again, the non-pIpC treated Kras G12D/C mice display a significantly shorter survival than the corresponding Nras G12D/G12D mice (Fig. 1B). These results clearly demonstrate that oncogenic Kras is a much more potent oncogene than oncogenic Nras in leukemogenesis.To decipher the unique function of oncogenic Kras signaling in leukemogenesis, we first investigated how loss of wild-type (WT) Kras impacts on adult hematopoiesis. 9 We found that loss of Kras leads to greatly reduced TPO signaling in haematopoietic stem cells (HSCs), while SCF-evoked ERK1/2 activation is not affected. The compromised TPO signaling is associated with reduced long term-and i...